Manufacture of bulk drugs at the heart of what we do
India’s first company to start commercial production of Anti-tuberculosis drug Rifampicin
Gujarat Themis Biosyn Limited was incorporated in 1981 as a joint sector company with GIIC Ltd. and Chemosyn (P) Ltd. It commenced production in August 1985. It was subsequently taken over in June 1991 by Yuhan Group, South Korea and Pharmaceutical Business Group (India) Ltd. (PBG); a unique consortium of five competing drug companies - Themis Medicare Ltd., Kopran Ltd., Anant & Co., Cadila Health Care Ltd. (Zydus) and Lyka Labs Ltd. It is being actively managed by Themis Medicare Ltd. (JV company of Gedeon Richter Ltd, Hungary) since 2007.
News Corner
2019-03-15 23:56:23 - lntimation under regulation 39(3) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulation, 2015 I“SEBI (LODR) Regulations: 2015″
2019-03-11 18:33:22 - Clarification on Price Movement of Gujarat Themis Biosyn Ltd. (Scrip Code: 506879)
2019-03-08 18:33:25 - lntimation under regulation 39(3) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulation, 2015 I“SEBI (LODR) Regulations: 2015"
2019-02-08 23:34:37 - Outcome of Board Meeting - 08 Feb 2019
2019-02-07 18:44:45 - lntimation under regulation 39(3) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulation, 2015 [“SEBI (LODR) Regulations, 2015"|
Annual Report 2017 – 2018